TY - JOUR
T1 - Assessing Physician-Patient Dialogues About Chronic Migraine During Routine Office Visits
AU - Buse, Dawn C.
AU - Gillard, Patrick
AU - Arctander, Kaitlyn
AU - Kuang, Amy W.
AU - Lipton, Richard B.
N1 - Funding Information:
Funding: Study sponsored by Allergan plc.
Funding Information:
Conflict of Interest: All authors met the ICMJE authorship criteria. Neither honoraria nor payments were made for authorship. Financial arrangements of the authors with companies whose products may be related to the present report are listed, as declared by the authors. Dr. Dawn C. Buse in the past 12 months has received grant support and honoraria from Allergan, Avanir, Lilly, and the National Headache Foundation. She is an employee of Montefiore Medical Center, which has received research support funded by Allergan, Alder, Avanir, Argus, CoLucid, Electrocore, Labrys, Merck, Dr. Reddy’s Laboratories, and Teva, both directly and via grants to the National Headache Foundation. She is on the editorial board of the Journal of Headache and Pain, Pain Medicine News and Pain Pathways magazine. Dr. Patrick Gillard is a full-time employee and stock/stock option holder of Allergan plc. Kaitlyn Arctander was a full-time employee of Verilogue, the company who was contracted to conduct this research, during the time of data analysis and manuscript drafting. Dr. Amy W. Kuang is a full-time employee and stock/stock option holder of Allergan plc. Dr. Richard B. Lipton has received honoraria from Allergan, American Headache Society, Autonomic Technologies, Boston Scientific, Bristol Myers Squibb, CoLucid, Electrocore, Eli Lilly, eNeura Therapeutics, Novartis, Vendanta, and Teva, holds stock options with eNeura Therapeutics, and has received research support from Allergan, Autonomic Technologies, Boston Scientific, Bristol Myers Squibb, Electrocore, Novar-tis, NuPathe, and Vedanta.
Publisher Copyright:
© 2018 American Headache Society
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Objective: To assess physician-patient communication and identify the frequency of use of specific communication techniques by analyzing recordings of routinely scheduled medical encounters for patients with clinician-identified chronic migraine. Background: Chronic migraine is an under-diagnosed, under-treated, and highly burdensome disease. Effective medical communication is integral to optimal medical care, including providing accurate diagnoses, creating effective treatment plans, and enhancing patient adherence. Communication patterns during office visits may be a target for intervention to improve outcomes for people with chronic migraine. Design: This was a prospective, observational study based on analysis of audio recordings collected during neurologist-patient chronic migraine dialogues. Methods: Twenty neurologists from a US neurology panel maintained by Verilogue, Inc., a research organization specializing in healthcare dialogues, were invited to identify patients with chronic migraine and record clinical encounters with their patients. Both new patient visits and follow-up visits were included in this analysis. Neurologist-patient dialogues were audio-recorded, anonymized, transcribed, and analyzed by a sociolinguist for the presence of prespecified communication parameters, strategies, and specific language indicative of optimal migraine-related medical care. Results: Fourteen out of the 20 invited neurologists (70.0%) accepted the study invitation and recorded 35 encounters with patients eligible for the study. The patient sample was 91.4% female (n = 32/35), with a mean age of 46 years. On average, there were 17 headache-related questions per visit; 82.0% of questions were closed-ended (n = 369/450). Headache/migraine frequency was elicited in 77.1% of the dialogues (n = 27/35), but headache days per month was assessed in only a single dialogue. Only one neurologist utilized the ask-tell-ask technique. Headache-related disability was discussed in 22.9%of the dialogues (n = 8/35), with only one using open-ended questions. None of the dialogues discussed ictal vs interictal headache-related disability. Chronic migraine was mentioned in 8.6% of dialogues (n = 3/35) and treatment plans were discussed in 37.1% of the dialogues (n = 13/35). Conclusions: Results from this preliminary study showed that the majority of the neurologist-chronic migraine patient dialogues did not assess elements crucial for diagnosis and treatment (eg, headache days per month and headache related disability) or use standard communication techniques (eg, open-ended questions, ask-tell-ask). We recommend intervention studies designed to assess the benefits of improved communication on diagnostic accuracy, treatment decisions, and patient reported outcomes.
AB - Objective: To assess physician-patient communication and identify the frequency of use of specific communication techniques by analyzing recordings of routinely scheduled medical encounters for patients with clinician-identified chronic migraine. Background: Chronic migraine is an under-diagnosed, under-treated, and highly burdensome disease. Effective medical communication is integral to optimal medical care, including providing accurate diagnoses, creating effective treatment plans, and enhancing patient adherence. Communication patterns during office visits may be a target for intervention to improve outcomes for people with chronic migraine. Design: This was a prospective, observational study based on analysis of audio recordings collected during neurologist-patient chronic migraine dialogues. Methods: Twenty neurologists from a US neurology panel maintained by Verilogue, Inc., a research organization specializing in healthcare dialogues, were invited to identify patients with chronic migraine and record clinical encounters with their patients. Both new patient visits and follow-up visits were included in this analysis. Neurologist-patient dialogues were audio-recorded, anonymized, transcribed, and analyzed by a sociolinguist for the presence of prespecified communication parameters, strategies, and specific language indicative of optimal migraine-related medical care. Results: Fourteen out of the 20 invited neurologists (70.0%) accepted the study invitation and recorded 35 encounters with patients eligible for the study. The patient sample was 91.4% female (n = 32/35), with a mean age of 46 years. On average, there were 17 headache-related questions per visit; 82.0% of questions were closed-ended (n = 369/450). Headache/migraine frequency was elicited in 77.1% of the dialogues (n = 27/35), but headache days per month was assessed in only a single dialogue. Only one neurologist utilized the ask-tell-ask technique. Headache-related disability was discussed in 22.9%of the dialogues (n = 8/35), with only one using open-ended questions. None of the dialogues discussed ictal vs interictal headache-related disability. Chronic migraine was mentioned in 8.6% of dialogues (n = 3/35) and treatment plans were discussed in 37.1% of the dialogues (n = 13/35). Conclusions: Results from this preliminary study showed that the majority of the neurologist-chronic migraine patient dialogues did not assess elements crucial for diagnosis and treatment (eg, headache days per month and headache related disability) or use standard communication techniques (eg, open-ended questions, ask-tell-ask). We recommend intervention studies designed to assess the benefits of improved communication on diagnostic accuracy, treatment decisions, and patient reported outcomes.
KW - chronic migraine
KW - communication
KW - sociolinguistic
UR - http://www.scopus.com/inward/record.url?scp=85046360234&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046360234&partnerID=8YFLogxK
U2 - 10.1111/head.13314
DO - 10.1111/head.13314
M3 - Article
C2 - 29727478
AN - SCOPUS:85046360234
SN - 0017-8748
VL - 58
SP - 993
EP - 1006
JO - Headache
JF - Headache
IS - 7
ER -